ClinicalTrials.gg
CompletedNCT05908201Updated Jun 23, 2026

Effects of Early Time Restricted Eating on Muscle Performance in Resistance Trained Individuals

An interventional study of early time restricted eating in Time Restricted Eating, sponsored by University of Mississippi, Oxford. Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-23.

Sponsored by University of Mississippi, Oxford · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 113 studies in Intermittent Fasting with a site in United States — 33 open to participants now, 44 under way, none of them phase 3. Intermittent Fasting · United States.

Enrollment
54th of 112
40 · median 40
Started
2023
with 15 others
No phase
104 of 113
26 open now
Registered
67th of 113
by date

Among the 113 studies in Intermittent Fasting with a site in United States, this one is the 54th largest by enrollment of the 112 interventional ones that give a count, is one of 16 that started in 2023, is one of 104 with no phase, and was the 67th registered.

Intermittent Fasting

334 studies on the registry are indexed under Intermittent Fasting; 100 are open to participants now.

Browse Intermittent Fasting studies →

Open to participants now

33 of the 113 studies in Intermittent Fasting with a site in United States are open now. Recruiting first, the newest first:

28 more — sign in →

All 33 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 74 Intermittent Fasting studies recruiting now, 19 (26%) set no upper age limit and 49 (66%) stop at 75 or younger; 4 take children under 18; 22 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 113 studies in Intermittent Fasting with a site in United States, or all of them as a file.
02

Study summary

A randomized controlled trial to determine the effectiveness of early time-restricted eating on muscle performance and body composition in active, resistance trained adults. Two parallel groups will be randomly assigned to either the early time-restricted eating or a control group. All participants will be asked to maintain their usual exercise routines during the 6 week intervention period. Muscle strength and endurance are the primary outcomes. Body composition (body weight, fat mass, fat-free mass and percent body fat), hunger and satiety ratings, sleep quality, energy intake, diet quality, macronutrient composition and adherence are secondary outcome measures.

03

Conditions studied

  • Time Restricted Eating

Browse trials for

Keywords

  • Intermittent fasting
  • Time restricted eating
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults between 18 - 50 years
  • Performing resistance training at least twice per week (for ≥1 yr)
  • ≥ 18.5

Exclusion criteria

Exclusion Criteria:

  • Currently sedentary or not engaged in resistance training.
  • Major surgeries in muscles/joints during the past 3 months
  • \< 18.5
  • Ineligible to engage in physical activity according to 2022 Physical Activity Readiness Questionnaire for everyone (PAR-Q+)
  • Take anabolic steroids or on hormone replacement therapy.
  • Current smoker.
  • Following restrictive diets (Vegan, vegetarian, intermittent fasting, Paleo, calorie restriction, keto/ low carbohydrate diet or any other restrictive diets)
  • Active cancer or cancer requiring treatment in the past 2 years (except non-melanoma skin cancer).
  • Musculoskeletal disorders
  • Diagnosed with cardiovascular disease including myocardial infarction, heart surgery, heart failure and had a heart transplant.
  • Have pacemaker or metal implants
  • Diagnosed diabetes (type 1 or 2).
  • Diagnosed hypertension or high blood pressure (>130/90).
  • Diagnosed eating disorder or score ≥ 20 on Eating Attitudes Test -26 (EAT26) survey
  • Missing limbs/ have prosthetics
  • Had surgery in joints/muscle in the past year.
  • Received medical advise against exercising due to medical reasons.
  • On medication for conditions related to the thyroid gland
  • Unwilling to commit for a 7-week study
  • Likely to move away from participating clinic before trial completed
  • Unable or unwilling to give
  • Another household member is a participant or staff member in the trial
  • Unwilling to accept treatment assignment by randomization
  • Current or anticipated participation in another intervention research project that would interfere with the intervention offered in the trial
  • Pregnant or \< 6 months since giving birth.
  • Any other condition which, in opinion of investigators, that would adversely affect conduct of the trial.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    early time-restricted eating

    The Early Time Restricted Eating (eTRE) group will be asked to consume calorie containing food or drinks only between 9am to 5pm, daily. At other times they are to avoid consuming any calorie containing food or drinks.

    Behavioral: early time restricted eating

  • No intervention
    Control

    The Control group will follow their usual eating routine.

Interventions

  • Behavioralearly time restricted eating

    The intervention group will eat in a prescribed daily feeding window (9am-5pm) and follow their normal exercise and resistance training routines. We will allow up till +/-1 hour for the eating window start and end times while aiming for an 8 hour eating window.

06

What researchers measure

Primary outcomes

  1. Muscular strength

    Pre and post intervention testing of muscular strength using one-rep max

    Time frame: 6-weeks

  2. Muscular endurance

    Pre and post intervention testing of muscular endurance using barbell bench press and squat.

    Time frame: 6-weeks

Secondary outcomes

  1. Body weight (kg)

    Pre and post intervention measures of body weight.

    Time frame: 6-weeks

  2. Hunger and satiety

    Pre and post intervention subjective measure of hunger and satiety with the use of a Hunger and Satiety Visual Analog Scale (minimum value zero, maximum value 10). Higher the score, the more hungry/ less satiated one is.

    Time frame: 6-weeks

  3. Sleep quality

    Pre and post intervention measure of subjective sleep quality by use of Pittsburgh Sleep Quality Scale. (each question can be scored from 0-3, then an aggregate score of the whole survey can range from 0-21; The higher the score the worst the sleep quality).

    Time frame: 6-weeks

  4. Total calorie intake

    Pre and post intervention measurements of calorie intake based on 24-hour food recall survey using the Automated Self-Administered 24-hour (ASA24) software.

    Time frame: 6-weeks

  5. Diet Quality

    Pre and post intervention measurements of diet quality based on 24-hour food recall survey using the ASA24 software and Healthy Eating Index.

    Time frame: 6-weeks

  6. Diet macronutrient composition

    Pre and post intervention measurements of macronutrients based on 24-hour food recall survey using the ASA24 software.

    Time frame: 6-weeks

  7. Adherence

    Percent of days during the 6-week trial when eTRE was adhered to as recommended. This will be recorded by the participants daily throughout the entire study.

    Time frame: 6-weeks

  8. Fat mass

    Pre and post intervention measurements of body fat mass (kg).

    Time frame: 6-weeks

  9. Fat-free mass

    pre and post intervention measurements of body fat-free mass (kg).

    Time frame: 6-weeks

  10. Body fat percentage

    Pre and post intervention measurements of body fat percentage.

    Time frame: 6-weeks

07

Study locations

1 site
  • Department of Nutrition and Hospitality Management, University of Mississippi
    University, Mississippi 38677, United States
08

References and documents

Individual participant data

Plan to share: Yes — We will share the de-identified participant data used in the published manuscript/s by depositing these data in the Open Science Framework (OSF) repository. The data shared will include the sociodemographic data and the outcomes published in the manuscripts. The protocol and statistical analysis plan will be shared as supplementary material through the journal where the study if published, if allowed.

Supporting information: Study protocol, Statistical analysis plan

Time frame: We agree to deposit outcome data into the OSF repository as soon as possible but no later than within two years after the last publication.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2023 to primary completion in Jun 2023, 3 months.

Of 259 non-industry interventional studies with no phase under Intermittent Fasting, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 34. This study's 3 months is below that.

Counting every sponsor, half of 265 studies reached it within 17 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 21, 2023
First posted
Jun 18, 2023
StartActual
Feb 20, 2023
Primary completionActual
Jun 17, 2023
CompletionActual
Jun 17, 2023
Last update
Jun 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05908201
Lead sponsor
University of Mississippi, Oxford
Responsible party
Sponsor
First posted
Jun 18, 2023
Start date
Feb 20, 2023
Primary completion
Jun 17, 2023
Completion
Jun 17, 2023
Last update
Jun 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion